Sights Set On Private Funding As Pharma Exec Appointed To Head New WHO Foundation Health Systems 07/12/2020 • J Hacker Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) Dr Tedros admitted there “could be a conflict of interest” as money would come from areas where WHO cannot mobilise directly. The WHO Foundation has appointed a senior pharma executive as CEO of the flagship WHO Foundation, suggesting it will make a big push to secure donations from the broader private sector as the curtain closes on a precarious budget year. But speaking at a press briefing on Monday, the WHO DG commented on the recruitment of an industry figure, Anil Soni of the US-based Viatris, to the WHO Foundation would create a whole new set of headaches in the form of potential conflict of interests with industry donors whose money WHO Foundation is soliciting – at the same time that the Organization must also act as a neutral broker for the worldwide endorsement of new pharma products. “The money will come from areas where WHO cannot mobilise directly … and where there could be a conflict of interest,” Tedros admitted. But since the relationships fostered with industry would be “indirect”, they wouldn’t pose a conflict of interest for WHO, as such. “So, the relationship between WHO and WHO Foundation is not direct,” he said. “So one thing I would like to assure you is that we have done all the assessments.” The WHO Foundation, which was launched in May 2020, operates as a separate legal entity, allowing it to recruit funds from the private sector and private individuals and use that money to invest in research and science-based initiatives for which WHO lacks adequate budget. Soni will be joining the WHO Foundation in January 2021 from the Pennsylvania-based company Viatris, formed in November 2020 as a combination Mylan N.V. and Pfizer’s Upjohn business, where he has worked as Head of Global Infectious Diseases for nearly 10 years. US President Donald Trump’s announcement in April to suspend the US funding to WHO, followed by his July announcement of a US withdrawal from the global health body, highlighted the delicate nature of the Organization’s resource base, which relies heavily on voluntary donations from member states as well as from other charities. Until April, the US was the biggest single donor to WHO, providing US$400 million in 2019, accounting for around 15% of its annual budget. Although the subsequent election of a new US president, Joe Biden, will see another US about-face, since Biden has declared his intention to rejoin WHO, the events of the summer, in the midst of a pandemic, underlined the precarious state of WHO’s budget: its programme budget for 2020-21 amounts to about US$5 billion a year. “If any of [our] donors withdrew their funding, WHO would experience a shock which it cannot absorb,” Dr Tedros said at Monday’s briefing, adding that since his election to head WHO in 2017, his “strategy solution … was for WHO to broaden its base of donors”. Soni has a two-decade career in the public, private and nonprofit sectors. He also served as CEO of the Clinton Health Access Initiative. Prior that he also worked for the Global Fund to Fight AIDS, Tuberculosis and Malaria between 2002-04 as the Advisor to the Executive Director, and he has been an advisor to the Bill & Melinda Gates Foundation: the second largest contributor to WHO’s annual budget this year, after Germany. Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) Combat the infodemic in health information and support health policy reporting from the global South. Our growing network of journalists in Africa, Asia, Geneva and New York connect the dots between regional realities and the big global debates, with evidence-based, open access news and analysis. To make a personal or organisational contribution click here on PayPal.